<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03679325</url>
  </required_header>
  <id_info>
    <org_study_id>COPDcardiac variability</org_study_id>
    <nct_id>NCT03679325</nct_id>
  </id_info>
  <brief_title>Evaluation of Cardiac Variability After a Vitamine D Protocol and Whole Body Vibration</brief_title>
  <official_title>Heart Rate Variability in Healthy Older and Older COPD After Vitamine D Use and Whole Body Vibration Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maíra F Pessoa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal de Pernambuco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of heart rate variability in time and frequency domains, in Chronic Obstructive
      Pulmonary Disease (COPD) after 03 months of vitamine D supplementation and whole body
      vibration (WBV) training
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 20, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">August 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>heart rate variability</measure>
    <time_frame>before and immediately after the chronic intervention</time_frame>
    <description>evaluation of time and frequency domains</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Copd</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>vitamine D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a dose once a week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamine D placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>a dose once a week</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamine D</intervention_name>
    <description>a dose once a week</description>
    <arm_group_label>vitamine D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>whole body vibration (WBV)</intervention_name>
    <description>03 months of WBV training three times per week</description>
    <arm_group_label>vitamine D</arm_group_label>
    <arm_group_label>vitamine D placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD or healthy elderly sedentary according to International Physical Activity
             Questionnaire

          -  BMI between 22.9 and 28 kg/m2

          -  COPD with clinical-functional diagnosis of the disease according to Gold

          -  ex-smokers

        Exclusion Criteria:

          -  Older patients with COPD who had episodes of exacerbation in the last three months

          -  Who participate in pulmonary rehabilitation programs in the last year

          -  Who used home oxygen therapy

          -  Patients with COPD-associated comorbidities

          -  Who were taking vitamin D
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Federal University of Pernambuco</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50670-901</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 19, 2018</study_first_submitted>
  <study_first_submitted_qc>September 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2018</study_first_posted>
  <last_update_submitted>September 20, 2018</last_update_submitted>
  <last_update_submitted_qc>September 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Pernambuco</investigator_affiliation>
    <investigator_full_name>Maíra F Pessoa</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

